[The efficacy of treating strongyloidiasis patients with medamine].
The efficacy and tolerance of medamin therapy for patients with strongyloidosis were studied in a focus of this disease in the Lenkoran District of Azerbaijan, situated in wet subtropical climatic zone. The studies were carried out at 6 rural hospitals. A total of 166 inpatients (n = 48) and outpatients (n = 118) were treated. The drug was sufficiently well tolerated and effective: 65.6 +/- 3.6% of the patients were cured after a single course of therapy. Complete cure was attained after 4 therapeutic courses.
Kuliev
N D
ND
Iarotskiĭ
L S
LS
Mekhraliev
M B
MB
Abdullaev
A D
AD
D000293:Adolescent; D000328:Adult; D000969:Antinematodal Agents / Q000627:therapeutic use*; D001382:Azerbaijan; D001562:Benzimidazoles / Q000627:therapeutic use*; D002219:Carbamates; D002648:Child; D002675:Child, Preschool; D002908:Chronic Disease; D004341:Drug Evaluation; D005243:Feces / Q000469:parasitology; D005260:Female; D006801:Humans; D008297:Male; D013322:Strongyloidiasis / Q000188:drug therapy* / Q000469:parasitology; D013607:Tablets
D000969:Antinematodal Agents; D001562:Benzimidazoles; D002219:Carbamates; D013607:Tablets; C006698:carbendazim
Effektivnost' lecheniia bol'nykh strongiloidozom medaminom.